An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment ...
A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...
Mass General Brigham, based in Somerville, Mass., is partnering with Philips to enhance real-time patient monitoring by integrating medical device data into a unified platform, a move aimed at ...
Axios Vitals on MSN1d
Your OB-GYN might be feeding you outdated menopause informationMenopause is something every woman goes through, but doctors — even OB-GYNs — aren't required to learn much about it. Why it ...
A union could address a host of issues, including cost-of-living raises, paid sick time, and a definition of “full-time work” ...
Mass General Brigham — then called Partners HealthCare — sparked an uproar when it announced plans to build outpatient ...
Marlise R. Luskin, MD, MSCE, discusses the trial of tagraxofusp in BPDCN, which showed high response rates and overall survival.
A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By ...
Dr. Yvon Woappi ’11, who researches wound healing and regeneration at his lab at Columbia University, will address the ...
The global board of medical experts was established by Statista to support the World's Best Hospitals project. This ...
The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...
Cross-sectional data showed that physicians in the U.S. had lower mortality rates than the general population. Physicians in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback